Overview

NCI Definition: An adenocarcinoma that arises from the endometrium and is characterized by the presence of both type I and type II endometrial adenocarcinoma components. The minor component constitutes at least 5% of the entire tumor. [1]

Endometrial mixed adenocarcinomas most frequently harbor alterations in TP53, PIK3CA, ARID1A, PTEN, and FBXW7 [2].

Most Commonly Altered Genes in Endometrial Mixed Adenocarcinoma

TP53 Mutation, TP53 c.217-c.1178 Missense, TP53 Missense, PIK3CA Mutation, and ARID1A Mutation are the most common alterations in endometrial mixed adenocarcinoma [2].

Top Alterations in Endometrial Mixed Adenocarcinoma

Significant Genes in Endometrial Mixed Adenocarcinoma

ERBB2 +

MLH1 +

MLH3 +

MSH2 +

MSH3 +

MSH6 +

PMS1 +

PMS2 +

Disease Details

Parent(s)
Endometrial Adenocarcinoma
OncoTree Name
Uterine Mixed Endometrial Carcinoma
OncoTree Code
UMEC

References

1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/ [2018-08-28]. [2018-09-21].

2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.

3. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.